Science News
from research organizations

Antiestrogen therapy may decrease risk for melanoma

Date:
January 4, 2012
Source:
American Association for Cancer Research
Summary:
Women with breast cancer who take antiestrogen supplements may be decreasing their risk for melanoma, according to a new study.
Share:
       
FULL STORY

Women with breast cancer who take antiestrogen supplements may be decreasing their risk for melanoma, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

Christine Bouchardy, M.D., Ph.D., professor at the University of Geneva and head of the Geneva Cancer Registry, and colleagues analyzed data from 7,360 women who had breast cancer between 1980 and 2005. About half (54 percent) of these women received antiestrogen therapy.

The researchers followed the patients until 2008 and recorded 34 melanoma cases during the follow-up period. Risk for melanoma was 60 percent higher among patients who did not receive antiestrogen therapy compared with patients who received antiestrogen therapy.

According to Bouchardy, the increased focus on estrogen's role in breast cancer has led scientists to start questioning what role estrogen is playing in other cancers. "These data reinforce the hypothesis that estrogens play a role in melanoma occurrence," she said.

Bouchardy said this may be due to the fact that estrogens are associated with increased levels of melanocytes and melanin production in human skin, which have been linked to early-stage melanoma. However, she cautioned against widespread antiestrogen supplementation to prevent melanoma in the general population.

"These results need to be replicated in other studies, particularly given the numerous side effects linked to this kind of drug," said Bouchardy.

The study was funded by a grant from the Swiss Research Foundation against Cancer, a nonprofit group.


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. Huber, C. Bouchardy, R. Schaffar, I. Neyroud-Caspar, G. Vlastos, F.-A. Le Gal, E. Rapiti, S. Benhamou. Antiestrogen Therapy for Breast Cancer Modifies the Risk of Subsequent Cutaneous Melanoma. Cancer Prevention Research, 2011; 5 (1): 82 DOI: 10.1158/1940-6207.CAPR-11-0332

Cite This Page:

American Association for Cancer Research. "Antiestrogen therapy may decrease risk for melanoma." ScienceDaily. ScienceDaily, 4 January 2012. <www.sciencedaily.com/releases/2012/01/120104115124.htm>.
American Association for Cancer Research. (2012, January 4). Antiestrogen therapy may decrease risk for melanoma. ScienceDaily. Retrieved May 25, 2015 from www.sciencedaily.com/releases/2012/01/120104115124.htm
American Association for Cancer Research. "Antiestrogen therapy may decrease risk for melanoma." ScienceDaily. www.sciencedaily.com/releases/2012/01/120104115124.htm (accessed May 25, 2015).

Share This Page: